Since β-catenin phosphorylation in colorectal cancer cells is impaired due to APC truncations or impossible due to β-catenin mutations, it is unlikely that increased GSK3 activity can be accounted for inhibition of Wnt/β-catenin signaling by SFN in SW480, DLD1 and HCT116 cells. This evidence concerns the gene APC and colorectal cancer.